Skip to content

Assessing the Effect of PRP (Platelet Rich Plasma) Injection in Healing of Diabetic Foot Ulcer

Comparison of the Effect of PRP (Platelet Rich Plasma) Injection Plus Standard Treatment and Just Standard Treatment in Healing of Diabetic Foot Ulcer in Diabetic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015021519037N5
Enrollment
50
Registered
2015-02-24
Start date
2014-09-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diabetes Mellitus. Condition 2: Diabetes Mellitus with Peripheral Circulatory Complications. Diabetes Mellitus Peripheral Angiopathy in Diseases Classified Elsewhere (Diabetic Peripheral Angiopathy / Ulcer)

Interventions

Intervention 1: First intervention group (Trial group): Daily cleaning of the ulcer with 1 litr normal saline as the standard treatment (normal saline solution 9mg/ml from Daroupakhsh drug manufacturi
Treatment - Drugs
First intervention group (Trial group): Daily cleaning of the ulcer with 1 litr normal saline as the standard treatment (normal saline solution 9mg/ml from Daroupakhsh drug manufacturing company, Teh
Second intervention group (Controll group): Just daily cleaning of the ulcer with 1 litr normal saline as the standard treatment (normal saline solution 9mg/ml from Daroupakhsh drug manufacturing com

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diabetic foot ulcer in patients with diabetes type 1 or 2 for at least 4 weeks. Exclusion criteria: Infected ulcers, ulcers with Charcot deformities, ulcers with bone involvement, ulcers with the size less than 0.5 or more than 20 cm, pregnant or nursing patients.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Healing rate of the ulcer. Timepoint: At the beginning of the treatment, 1, 2, 3 and 4 weeks after the beginning of the treatment. Method of measurement: Assessing by one surgeon and documentation.;The size of the ulcer. Timepoint: At the beginning of the treatment, 1, 2, 3 and 4 weeks after the beginning of the treatment. Method of measurement: Measuring by ruler and documentation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hossein Parsa

Qazvin University of Medical Sciences

hoparsaar2004@yahoo.com+98 28 3379 0620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026